此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Diagnostic Efficiency of Artificial Intelligence for Surgical Neuropathology

2020年12月15日 更新者:Jinsong Wu

A Multi-center, Prospective, Self-Controlled Diagnostic Accuracy Comparative Studies of Artificial Intelligence Diagnostic System for Surgical Neuropathology

This is a multi-center, prospective, self-controlled, diagnostic accuracy comparative study of Artificial Intelligence Diagnostic System for Surgical Neuropathology. The investigators will compare the diagnostic efficiency of Artificial Intelligence with that of practicing pathologists, and suppose that the diagnostic efficiency of artificial intelligence in prospective clinical data is no less than that of pathologists.

研究概览

详细说明

In this study, 141 patients will be recruited. After being enrolled, the patients will accept surgery and specimens for pathological analysis will be taken according to the routine treatment process.

The histopathologic slides will then be digitized by a whole-slide scanner. The images will be reviewed by gold standard committee for evaluation of ground truth. And then be separately diagnosed by Artificial Intelligence Diagnostic System and practicing pathologists. So the investigators can compare the diagnostic efficiency of Artificial Intelligence with that of pathologists, thus understand the gap between artificial intelligence and actual clinical practice.

研究类型

介入性

注册 (预期的)

141

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  1. Patients or their guardians understand the research process, agree to use their data, and sign the informed consent form;
  2. Aged >=18 years;
  3. MRI shows intracranial spaceoccupying lesions;
  4. The clinical diagnosis is glioma, metastasis or lymphoma thus requiring surgical treatment;
  5. The patient is willing to accept the surgery.

Exclusion Criteria:

  1. The patient has serious underlying diseases thus is not suitable for surgery;
  2. After further clinical evaluation, surgical treatment was not the best choice;
  3. The patient participate in clinical research of other drugs or devices;
  4. The researchers believe that there are other factors that will make the patients unable to complete the study.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:诊断
  • 分配:非随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Artificial Intelligence
A deep learning based artificial intelligence diagnostic system(DOI:10.1093/neuonc/noaa163)
The investigators will use the Artificial Intelligence Diagnostic System to review the H&E stained slide of each patient and then report the classification of the tumor on a 10-type scale.
有源比较器:Practicing Pathologists
One pathologist who has at least 5 years of experience
The ordinary pathologist will review the H&E stained slide of each patient(without additional informations such as: Immunohistochemistry et al.) and then report the classification of the tumor on a 10-type scale only bases on the slide images
其他:Gold Standard
A committee composed of two expert pathologists who has at least 10 years of experience and one expert pathologist who has at least 15 years of experience
Firstly, the two expert pathologist(>=10 years of experience) will review the H&E stained slide of each patient on their own (with additional informations such as: Immunohistochemistry et al.) and then report the classification of the tumor on a 10-type scale.If they report the same opinion, that opinion will perform as the ground truth; while if their opinion clash with each other, the expert pathologist(>=15 years of experience) will get involved and the agreement of three experts will perform as the ground truth

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Diagnostic Accuracy of Study Arms
大体时间:1 week after the last patient's diagnosis is completed
The number of correctly diagnosed participants by study arms divided by the total number of participants
1 week after the last patient's diagnosis is completed

次要结果测量

结果测量
措施说明
大体时间
Sensitivity and specificity of Study Arms
大体时间:1 week after the last patient's diagnosis is completed
Sensitivity and specificity of study arms for each type calculated by 2x2 tables
1 week after the last patient's diagnosis is completed
Spearman Coefficient of Study Arms related to Gold Standard
大体时间:1 week after the last patient's diagnosis is completed
Spearman Correlation Analysis between Study Arms and Gold Standard
1 week after the last patient's diagnosis is completed

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

调查人员

  • 研究主任:Cuiyun Wu, Ph.D、Huashan Hospital

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (预期的)

2021年2月1日

初级完成 (预期的)

2022年2月1日

研究完成 (预期的)

2022年2月1日

研究注册日期

首次提交

2020年12月4日

首先提交符合 QC 标准的

2020年12月15日

首次发布 (实际的)

2020年12月17日

研究记录更新

最后更新发布 (实际的)

2020年12月17日

上次提交的符合 QC 标准的更新

2020年12月15日

最后验证

2020年12月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅